Trending
November 19, 2024 LB Pharmaceuticals Appoints Heather Turner as CEONovember 19, 2024 Kevin Krause Appointed CEO of ArrePAthNovember 14, 2024 myBiometry Secures $5M to Seek Regulatory Sanction for Device for Asthma PatientsNovember 13, 2024 Metsera Secures $215 Million Series B FinancingNovember 12, 2024 Fort Health Raises $5.5M
Featured
November 19, 2024
LB Pharmaceuticals Appoints Heather Turner as CEO
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company... Read more »
November 19, 2024
Kevin Krause Appointed CEO of ArrePAth
PRINCETON, N.J.--(BUSINESS WIRE)--ArrePath, Inc., an emerging biotechnology company focused on applying deep phenotypic... Read more »
November 14, 2024
myBiometry Secures $5M to Seek Regulatory Sanction for Device for Asthma Patients
Boston-based myBiometry, which is developing a device to help patients with asthma and chronic obstructive pulmonary... Read more »
